Stina Singel
Chief Tech/Sci/R&D Officer bei ASCENDIS PHARMA A/S
Vermögen: 412 543 $ am 31.03.2024
Profil
Stina Singel's career history includes current and former positions as well as education.
Currently, Dr. Singel is the Executive VP & Head-Clinical Development at Ascendis Pharma A.
Previously, Dr. Singel worked as the Senior Medical Director at Genentech, Inc. from 2014 to 2019 and as the SVP, Head-Clinical Development & Drug Safety at Nektar Therapeutics from 2019 to 2020.
Dr. Singel holds a doctorate degree from The Salk Institute for Biological Studies and the University of California San Diego, as well as an undergraduate degree from Harvard University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
ASCENDIS PHARMA A/S
0,01% | 31.12.2023 | 2 729 ( 0,01% ) | 412 543 $ | 31.03.2024 |
Aktive Positionen von Stina Singel
Unternehmen | Position | Beginn |
---|---|---|
ASCENDIS PHARMA A/S | Chief Tech/Sci/R&D Officer | 01.05.2020 |
Ehemalige bekannte Positionen von Stina Singel
Unternehmen | Position | Ende |
---|---|---|
NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01.05.2020 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01.04.2019 |
Ausbildung von Stina Singel
The Salk Institute for Biological Studies | Doctorate Degree |
Harvard University | Undergraduate Degree |
University of California San Diego | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
NEKTAR THERAPEUTICS | Health Technology |
ASCENDIS PHARMA A/S | Health Technology |
Private Unternehmen | 1 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |